Dr. James Hamilton Jerkins, MD

Dr. Jerkins practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Jerkins' NPI, 1144414798, was assigned on August 28, 2007. Dr. Jerkins graduated from Loma Linda University School of Medicine in 2007. Dr. Jerkins holds Tennessee license 679777.

Dr. Jerkins' primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Jerkins' primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Jerkins to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jerkins practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jerkins' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Jerkins' licenses on file in 4 states: Tennessee, California, Ohio and Wisconsin.

CMS data shows 567 Medicare services from Dr. Jerkins across 6 procedure codes in 2024, for 126 Medicare patients. Medicare paid $39,642 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Jerkins in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jerkins' median patient age at 67, with 47% women.

In 2024, Dr. Jerkins wrote 379 Medicare Part D claims for 62 patients. 71% of them were for generic drugs. CMS names the drug for 248 of them, across 13 drugs with 11 or more claims each, at $823,436 in total drug cost. In 2023, CMS named 91 claims across 4 drugs.

Dr. Jerkins accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jerkins as offering telehealth.

Dmand AI links 26 papers to Dr. Jerkins, published from 2010 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Cyclophosphamide. Dr. Jerkins has published most often in Biol Blood Marrow Transplant. Dr. Jerkins' most frequent co-authors are Saurabh Chhabra, MD, Parameswaran N. Hari, MD and Binod Dhakal, MD.

Dmand AI links Dr. Jerkins to 1 clinical trial. Conditions studied include Anemia, Sickle Cell and Anemia, Hemolytic, Congenital.

CMS Open Payments shows 5 general payments to Dr. Jerkins from 5 drug and device companies from 2018 to 2023. Consulting fees make up the largest share, 97% of the total. Omeros Corporation paid the most, $15,000.

Dr. Jerkins graduated from Loma Linda University School of Medicine in 2007.